90%

Faster than traditional drug development.

0

Wetlab experiments. Patients needed until P2.

20%

Better models than PRS.

7

Assets currently in development in pipeline.

Newsroom

See What We’ve Been Up To


Mon Oct 18 2021

The Therapeutic Gap in COVID-19

Passive immunity shows a beneficial effect in the earliest stage of COVID-19 infection, prior to onset of symptoms, while immunosuppressants are beneficial for patients with critical respiratory failure much later in the course of infection. Therefore, a therapeutic gap exists and must be filled if the infection is not detected early and disease escalation is to be prevented.

Fri Oct 29 2021

Biotx BEYOND Webinar 3

We're excited to host our 3rd biotx BEYOND webinar. This time it will be all about synthetic clinical trials and causal inference in clinical risk prediction models, and so bringing better treatments to patients faster.

Speakers will be Dr. Stefan Konigorski from the Hasso-Plattner-Institute and our own Dr. Marco Schmidt.

It will be on Dec 8, 2021 04:00 PM CET / 09:00 AM CST

Register here:

https://zoom.us/webinar/register/WN_4pyTwwkVTqu4tgOV9VuiaA